Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN96269039) titled 'Pilot study of folinic acid vs folic acid supplementation in pregnant women with folate receptor alpha autoantibodies to lower the risk of autism and learning disorders in their children' on May 23.
Study Type: Interventional
Study Design:
Single-centre randomized double-blind placebo-controlled parallel-group pilot trial (Prevention)
Primary Sponsor: Altamedica
Condition:
Neurodevelopmental disorders, specifically autism spectrum disorder and early learning disabilities in offspring of pregnant women with folate receptor alpha autoantibodies
Mental and Behavioural Disorders
Intervention:
Participants will b...